News for Accustem Sciences Limited (ACMSY)

Published at

Jan 21, 2023 2:05 AM

by seekingalpha.com

positive

positive

Cancer diagnostics maker Accustem files for Nasdaq uplisting, $11M offering

Oncology diagnostics developer Accustem Sciences (ACUT) has filed to uplist its shares to Nasdaq and raise $11M. Its the third biotech to file this week. Read more here.

ACMSY

Read more →
Published at

Nov 19, 2022 12:18 AM

by seekingalpha.com

positive

positive

Cancer test developer Accustem seeks Nasdaq uplisting, $10M offering (OTCMKTS:ACUT)

Oncology diagnostics developer Accustem Sciences (ACUT) has filed to uplist its shares to Nasdaq and raise a proposed $10M through a public offering. Read more about Accustem here.

ACMSY

Read more →
Published at

Mar 1, 2022 2:37 PM

by marketscreener.com

mixed

mixed

Tiziana Life Sciences : StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort

New York, March 1, 2022 - Tiziana Life Sciences Ltd. reports that its' former subsidiary, AccuStem Sciences, Inc. , today announced publication of new data in the European Journal of Cancer.... | March 1, 2022

ACMSY TLSA TIZAF

Read more →